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Escherichia coli and sudden infant
death syndrome
Karl A. Bettelheim and Paul N. Goldwater*
Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, North Adelaide, SA, Australia
This review examines the association of strains of Escherichia coli with sudden infant
death syndrome (SIDS) and the possible role these bacteria play in this enigmatic
condition. The review addresses evidence for E. coli in SIDS infants, potential sources
of E. coli in the environment, colonization by commensal and pathogenic strains, the
variety of currently accepted pathotypes, and how these pathotypes could compromise
intestinal integrity and induce inflammation. Both intestinal and extraintestinal pathotypes
are compared in relation to the apparent liability in which virulence traits can be gained or
lost by strains of E. coli. The way in which E. coli infections fit with current views on infant
sleeping position and other SIDS risk factors is highlighted.
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Commensal and Pathogenic Escherichia coli
While Escherichia coli and “coliform” bacteria are considered part of the normal microbiome of
the human intestinal tract, they have been identified in studies of infants who died suddenly and
unexpectedly, infants classified either as sudden infant death syndrome (SIDS) and more recently
sudden unexpected death in infancy (SUDI) (1–3). When confined to the gut, these bacteria are
generally considered harmless; however, a number of pathotypes of E. coli can cause disease in
humans and animals. The pathotypes are characterized by their ability to produce certain virulence
factors, toxins and adhesins. They include enteropathogenic E. coli (EPEC), enterotoxigenic E. coli
(ETEC), enteroaggregative E. coli (EAgEC), Shigatoxigenic E. coli (STEC) [verotoxigenic E. coli
(VTEC)], enteroinvasive E. coli (EIEC), and diffuse adherent E. coli (DAEC). Their characteristics
will be considered in more detail below.
All E. coli are not the Same
Until 1940s, pathogenic E. coli were not identified; they could not be distinguished by techniques
available from non-pathogenic commensal E. coli. The pioneering work of Kauffmann in developing
a serotyping scheme enabled strains belonging to certain O:H serotypes to be linked to certain of the
pathotypes. For many years, EPEC was only recognized by serotypes until specific virulence factors
were identified.
Mechanisms by which the pathogenic E. coli gain access to and remain within a susceptible host
were unknown but considered likely to be similar to that of commensal E. coli over extended periods
of co-evolution. Studies on commensal E. coli in 1970s provided a basis for understanding the
colonization of the human body by E. coli.
Commensal Strains
In the first of these studies (4), the complete feces from 9 healthy adults were examined with 10 sites
on each specimen assessed and at least 10E. coli-like colonies collected from each site. These revealed
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a great diversity of types, although in all stools except 1 a single
predominant type was present at all 10 sites. This indicated that
generally when an E. coli isolate is selected from a fecal specimen,
it is likely to be the predominant type, but minor types might be
missed.
An extensive study on neonates’ acquisition of E. coli (5) found
“E. coli are present in the vagina of women and that the acquisition
of these E. coli by babies is related to the length of time that
the birth takes. It was also noted that there is a relationship
between the E. coli found in the feces of the mothers, the mucus
swallowed by the babies at birth, and subsequently in the feces of
the babies’. While this might be how infants acquire their E. coli
and other microflora, it was noted that “Caesarian section babies
are generally not likely to become colonized by their mothers’
fecal E. coli.” They were, however, colonized as rapidly as vaginally
delivered babies. These studies showed that the babies’ gut was
colonized early and these colonized babies became the foci for
spread of E. coli to other babies. Environmental studies indicated
that “contaminated hands and uniforms of the nursing staff may
be the main vector for transmitting E. coli.” It was also noted that
these E. coli acquired or lost certain traits during their spread
including antibiotic resistance, serological variation, and even bio-
chemical characteristics (6). Spread of E. coli was to a maximum
of four other infants; Caesarian babies were particularly prone to
colonization by these types of E. coli.
Pathotypes
Studies on commensal E. coli summarized above were in part
inspired by two earlier studies. The first was initiated as a result of
a survey on E. coli urinary-tract infection (UTI) among patients
who had been admitted to a female general medical ward over a
period of 2 years (7). The use of an extensive set of E. coli typing
antisera enabled a more complete identification and analysis. It
was noted that the O types responsible for most of the infections
belonged to relatively few common types.
Patients with diabetes, malignant disorders, rheumatoid arthri-
tis, and hypertension had a much higher incidence of E. coli UTI
than the rest of the ward population. In addition, there were
small epidemics of UTI due to specific E. coli O types in the
ward. These studies showed that none of these was acquired by
catheterization or instrumentation. The evidence accorded with
an oral transmission of type-specific E. coli from the intestinal
reservoirs of human carriers.
Among 20 patients (8) who had previously been free ofUTI and
who developed infection, 13 developed these infections within
12 days of gynecological operations accompanied by insertion of
a self-retaining catheter. The infections were caused by a type,
which had been present before the operation in the rectum,
vagina, or both.
These studies indicate that commensal E. coli can be
transmitted among infants and individuals who are susceptible
can acquire such E. coli, observations that could be relevant to
susceptibility of both neonates (especially premature) and women
who developed UTI.
Investigations carried under the sponsorship of the military
authorities examined the cause of travelers’ diarrhea, which affects
individuals newly arrived in a foreign country, usually within
14 days of arrival (9). A group of 540 British soldiers traveled by
air from England to Aden; of these 38 had an episode of diarrhea
during their first 14 days after arrival. Fecal specimens from 35
were investigated and 2 yielded strains of Salmonella spp., no
known pathogens were isolated from the remaining 33. A new
serotype ofE. coli (O148.H28)was isolated in the acute phase from
19 of these cases. In the remaining 14 (40%) cases, a number of
different E. coli serotypes were isolated. These included serotypes
associatedwith infantile diarrhea and not related to travelers’ diar-
rhea. The peak of the isolations of E. coliO148:H28 corresponded
with the peak incidence of travelers’ diarrhea. This serotype was
never isolated from a healthy subject. A year later, in a laboratory
in England, a technician working with this serotype developed a
severe episode of diarrhea and E. coli O148:H28 was recovered
in pure culture from his stools. The same serotype as well as
O6:H16 were subsequently isolated from American soldiers in
Vietnam (10).
Since these early discoveries at least 78 detectable O antigens
and 34 H antigens associated with ETEC have been described.
Among themost common serotypes, which produce either the so-
called heat stable enterotoxin (ST), heat labile enterotoxin (LT),
or both are O6:H16 (LT/ST), O8:H9 (ST only), O25:NM (LT
only), O78:H12 (ST only), O148:H28 (ST only), and O153:H45
(ST only). Their prevalence and phenotypes [based on the toxins
they carry or the colonization factors (CFs) they express] can vary
depending on the location. Many of these serotypes were also
commonly isolated from environmental sources and human cases
and outbreaks around the world (11). These studies confirmed
that E. coli can be true pathogens as well as commensal and they
can be acquired and shed by humans.
In 1983, a mild outbreak of diarrhea occurred in the neonatal
ward (12), in which the earlier studies on the spread of commensal
E. coli had been carried out (5, 6). Despite introduction of strict
control measures, the epidemic strain (O125:K70:H21) spread to
16 infants while the commensal strains spread maximally to 4
infants, similar to the spread observed in the previous study for
which no specific containment had been undertaken. Commensal
E. coli spread to other infants unimpeded and the outbreak strain
spread far more than the commensals.
Initially, EPECwas identified on the basis that certain serotypes
were regularly associated with infantile gastroenteritis, but the
actual virulence factors were not known. Following discovery of
the virulence factors, theywere shown to be present not only in the
currently isolated EPEC strains but also in original archival EPEC
strains, isolated long before the description of these virulence
factors (13) demonstrating that EPEC comprised a specific lineage
of pathogenic E. coli.
Shigatoxigenic E. coli or VTEC are another pathotype first
described in 1977 (14) in a study of the effects of culture super-
natants from various E. coli on different cell lines including
Vero cells (14). While a number of different serotypes were
identified as being associated with these pathotypes (15) one
serotype (O157:H7), first described in 1983 (16) has dominated
the STEC/VTEC literature. It was soon realized that the Vero-
toxins were similar to the Shiga toxin associated with strains of
Shigella dysenteriae, which had been described as long ago as
1903 (17, 18). Non-O157 STEC/VTEC was generally overlooked
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in the early years of STEC/VTEC research, but their impor-
tance as causes of sporadic and outbreak disease is now well
established (15).
It has been shown over the years that various “mobile genetic
elements,” such as transposons, insertion sequences, bacterio-
phages, and plasmids, can exist either integrated into the chromo-
some or through self-replication within the new host to provide
new traits and fitness advantages. Most definable virulence factors
found in pathogenic E. coli are derived from genetic mobile ele-
ments. For example, most of the genes for toxins and CFs required
for the pathogenesis of ETEC are found almost exclusively on
plasmids (11). These plasmids can move between strains supply-
ing a variety of palettes of virulence factors. A recent example of
this type of interaction was shown with the mixing of virulence
factors, resulting in one of the most serious outbreaks caused by
E. coli. This was the outbreak in 2011 (19) due to enteroaggregative
E. coli O104:H4 strains, which were also able to produce Shiga
toxins and which affected around 4000 individuals in Germany
and many more in 16 other countries. Recently, it was shown
that the enteroaggregative strain had acquired the bacteriophage
coding for Shiga toxin 2a in cattle (20). Most E. coli infections
are enteric. Extraintestinal infections, such as UTI and neonatal
meningitis, probably, also have an enteric origin (7, 8, 21). This
could have implications in regards to SIDS (vide infra).
Escherichia coli and SIDS
Sudden infant death syndrome remains a major cause of death
of infants under 1 year of age. It was defined as long ago as 1969
(22), and its cause remains enigmatic. A large number of studies
by both us and others have suggested that a bacterial infectionmay
be a contributing or causal factor (23–30). E. coli is often identified
in these infants. α-Hemloysin (HLyA)-producing serotypes of E.
coli causing urinary tract and other extraintestinal infections are
more commonly isolated from SIDS infants (29). These include
O1:H , O1:H5, O2:H1, O4:H5, O6:H1, O25:H1, and O75:H5
(31). A recent study (32) found that the α-HLyA of E. coli triggers
intestinal inflammation in mouse models of inflammatory bowel
disease by impairing the intestinal barrier thereby intensifying
antigen uptake. α-HLyA-producing E. coli were more commonly
isolated from the humanmucosa in patients with active ulcerative
colitis than in controls. α-hemolysin-producing E. coli needs to be
considered in SIDS. The effects of HLyA and/or Ehly on the ente-
rocyte and gut wall integrity could result in mucosal perturbation
or damage promoting translocation of bacteria (E. coli or other
gut microbiota) into the bloodstream either through induced
inflammation or directly [see below and the accompanying article
by Goldwater (33)].
The α-hemolysin is synthesized as a 1024-amino acid polypep-
tide, and then intracellularly activated by specific fatty acyla-
tion. A second activation step takes place in the extracellular
medium through binding of Ca2+ ions (Ca2+ HlyA) (34). Recent
studies have further shown that α-HLyA of E. coli interacts
directly with cholesterol (35). These studies note that the inser-
tion of α-HLyA is favored in cholesterol- and sphingomyelin-
containingmembranes. These studies, which demonstrated a clear
interaction between α-HLyA and cholesterol, show this favors a
conformational change of the α-HLyA that permits its correct
insertion into the membrane to form membrane pores. Some
strains of E. coli produce a different hemolysin from α-hemolysin,
i.e., enterohemolysin (Ehx or Ehly), which is especially associ-
ated with STEC, although not all STEC produce it. There are
enterohemolysin-producing E. coli that do not produce the Shiga
toxins (36).
Enterohemolysin was shown to be a toxin and a member of
the RTX (repeats-in-toxin) family of toxins. In its free form, it is
lytic toward human endothelial and intestinal epithelial cells. It is
also associated with outer membrane vesicles (OMV). The role of
these OMVs was largely unknown (37). Their investigation (37)
involved microscopic, biochemical, flow cytometry, and func-
tional analyses of human brain microvascular endothelial cells
(HBMEC) and Caco-2 to examine the role of OMV-associated
toxins. These demonstrated that OMV-associated enterhemolysin
does not lyse the target cells but triggers their apoptosis. Fol-
lowing internalization of the OMV-associated enterhemolysin by
HBMEC and Caco-2 cells, a cascade ensues, which lead to apop-
totic cell death as demonstrated by DNA fragmentation and chro-
matin condensation in the intoxicated cells. This ability of OMV-
associated enterohemolysin to trigger themitochondrial apoptotic
pathway in human microvascular endothelial and intestinal cells
is considered to be a newly recognized mechanism for a bacterial
toxin to enter host cells in order to target mitochondria. As far
as is known, the production of enterolysin by SIDS-associated E.
coli has not been fully investigated; however, we have observed
Ehly to be common in SIDS strains (unpublished). A rapid test
for the production of enterohemolysin by E. coli is available (38).
STEC has been identified in bovine feces and non-shiga-toxigenic
E. coli, which belong to typical STEC serotypes; these carry most
of the STEC virulence factors apart from being Shiga toxigenic
in many cases also produce enterohemolysin (36). Such E. coli
are known as atypical enteropathogenic E. coli (aEPEC) and have
also been found to be present in patients with STEC infections
and it appears that the acquisition or loss of the phage coding
for the production of Shiga toxin in patients infected with STEC
(39) is a not uncommon phenomenon. This was first described in
2005 (40).
It has been demonstrated (41) that certain ETEC that cause
travelers’ diarrhea produce a protein, EatA, a plasmid-encoded
serine protease, which degrades MUC2, which is a major protein
present in the mucus layer of the small intestine. The removal
of MUC2 accelerates the access of the ETEC enterotoxins to
the enterocyte surface. While this has not been sought in SIDS-
associated E. coli, the fact that some of these strains can produce
this factor does not preclude others also producing this or similar
factors. Other studies (42) show that another factor, YghJ, is highly
conserved in ETEC and is a metalloprotease that degrades the
major mucins, MUC2 and MUC3. This metalloprotease has also
been found to be present in other E. coli, including the enteroag-
gregativeE. coliO104:H4 and even strains ofVibrio cholerae. These
have not yet been investigated in SIDS.
Of relevance is a study in baboons on acute respiratory distress
syndrome (ARDS) (43), which mimics E. coli sepsis in humans.
The baboon model displays the early inflammatory phase with
extensive necrosis. If certain E. coli can cause ARDS, then it is
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possible that a similar mechanism occurs in SIDS given that the
clinical and pathological findings in SIDS babies reflect a process
consistent with sepsis and/or toxemic shock. This is supported by
sterile site evidence of bacteremia (33, 44, 45) and the knowledge
that bacteremia is a profound inducer of hypoxemia (thought to be
involved in the final pathway). This model is supported by clinical
evidence of fever [sweat-soaked bedding (46) and raised rectal
temperature (47) and the pathological findings of intrathoracic
petechiae, heavy wet lungs, and liquid heart blood and elevated
fibrin degradation products (48, 49)], findings compatible with a
process of bacterial sepsis. The physiological findings of hypox-
emia and bradycardia and asystole observed in monitored babies
dying of SIDS (50), again point to bacterial sepsis or toxemia as
the final event in SIDS.
Unfortunately, systematic studies have not been performed
where isolates of E. coli obtained from cases of SIDS and from
healthy infants have been subjected to a full battery of all the pos-
sible toxins and virulence factors that are known to be produced
by E. coli. Perhaps, such systematic studies will be undertaken in
the future. Direct toxin identification studies might be possible in
body fluids, such as urine, in which kidneys concentrate or filter
circulating bacterial toxins from the bloodstream. Preliminary
unpublished data indicate urine to be a useful fluid for toxin detec-
tion utilizing advanced proteomic techniques (Morris, personal
communication). This work could provide the breakthrough that
has been too long awaited by SIDS researchers.
SIDS Risk Factors in Relation to
Acquisition of E. coli
Bed Sharing
An association between bed sharing and SIDS has been noted (51,
52); however, why bed sharing occurred on the occasion of the
last sleep has not always been clearly defined. A recent study (53)
systematically reviewed the issue but only partially answered such
questions as Was the child unsettled/unwell which led to the baby
joining the parents in their bed? The review divided reasons for
bed sharing into either “intentional” or “reactive;” “monitoring”
the baby was given as a reason in 56.9% of situations (66.7%
in Blacks) and “crying” in 32.4%. These results could indicate
that SIDS babies were unwell on the last sleep. Clearly, further
refinement in reasons for bed sharing and the interactions with
other environmental factors is needed. Babies of families that
regularly bedshare seem to be at low risk of SIDS (54). Also, the
effect of parental drug/alcohol consumption has been taken to
imply that this would lead to overlaying. An alternative hypothesis
would be that drug-affected adults might not be alerted to an
unwell/unsettled baby. An even more basic suggestion is that the
infants acquire E. coli flora from close contact with parents or their
bed linen.
While such questions remain unanswered, it is generally sug-
gested that parents should share the room but not the bed with
the infant (55, 56). An extensive study was undertaken in USA. to
determine those trends and factors that might be involved with
bed sharing over a period from 1993 to 2010 (57). This study,
which was conducted through approximately 1000 telephone
interviews annually, showed that therewas a steady increase in bed
sharing throughout the period of study. A further study suggested
that breastfeeding might be affected by bed sharing (58) and
vice versa (53). In another study (59), the authors identified as
“three areas of concern” being (a) the baby sleeping in areas other
than crib or bassinet, (b) bed sharing, and (c) non-supine sleeping.
Mode of Delivery
A number of environmental factors have been investigated
with regard to acquisition of bacteria by neonates (4–6). Mode
of delivery (Cesarean or vaginal delivery) being important.
There are indications that bacterial characteristics also play
an important role in dissemination, acquisition, and successful
colonization (12).
Used Cot Mattresses
The association between used cot mattresses and SIDS (60) was
investigated by assessment of used polyurethane foam cot mat-
tresses. The bacterial population density was greatly increased in
used mattresses. E. coli was isolated from the dorso region of the
mattresses, significantly so if the infant slept in the prone position,
another significant risk factor for SIDS (61).
SIDS Risk Factors in Relation to
Acquisition of and Effects of E. coli
Viral Respiratory Infections
Experimental studies have indicated that mild virus infection
might potentiate the inflammatory response to bacterial toxins,
particularly endotoxins. Moscovis et al. (this issue) (62) demon-
strated in a model system that interferon-γ (IFN-γ) significantly
enhanced pro-inflammatory response to endotoxin and signifi-
cantly reduced the anti-inflammatory IL-10 response. The effects
of IFN-γ on responses to the soluble E. coli toxins have not been
examined.
Environmental Pollutants
A recent preliminary study (63) showed that the intestinal bac-
terial flora of neonates is influenced by house dust. Using high
through-put sequence analysis of portions of the16S rRNA gene,
it was found that despite significant differences between the dust
and fecal microbiota as revealed by non-metric multidimensional
scaling (NMDS) analysis, permutation analysis confirmed that 14
bacterial operational taxonomic units (OTUs) representing the
classes Actinobacteria, Bacilli, Clostridia, and Gammaproteobac-
teria co-occurred at a significantly higher frequency in matched
dust–stool pairs than in randomly permuted pairs, indicating an
association between these dust and stool communities.
A study (64) of house dust and its relation to the skin surface
swab samples of occupants in four homes were analyzed for
their bacterial content using more accurate culture-independent
methodology. Species-level operational taxonomic units (SLO-
TUs) were used to compare the results. Phylogenetic descrip-
tion of SLOTUs of the bacterial sequences was analysed from
the different house dusts and skin surface swabs, which repre-
sented random samples of bacteria present in a given sample. The
study (65) showed that the presence of bacterial endotoxins in
house dust and investigated the role that they may play in the
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development of allergen sensitization. As LPS is also a powerful
inducer of inflammatory responses, these findings require more
investigation.
A preliminary investigation of the gut micro flora in SIDS
compared the intestinal contents from 52 SIDS cases, with 102
fecal samples from age-matched live comparison infants (66).
These were screened by PCR to target 16s RNA genes of Clostrid-
ium innocuum, Clostridium perfringens, Clostridium difficile, Bac-
teroides thetaiotaomicron, and Staphylococcus aureus. While E.
coli were not included in these studies, the distribution of the
test microorganisms can be used to extrapolate the possible roles
of E. coli. The paper showed that the gut microbiome of SIDS
babies differs from that of normal babies. The major finding was
significantly more babies dying prone were colonized by S. aureus
colonization than babies similarly colonized but dying in other
positions (supine/side) (odds ratio= 20.25; CI= 3.60–134.92).
This supports the hypothesis that prone sleep position increases
the risk of such colonization by S. aureus and E. coli (61) or induc-
tion of temperature dependent toxins, such as the staphylococcal
pyrogenic toxin (67), as the nasal temperature of infants in the
prone position is significantly raised. There was a highly signifi-
cant association between pronesleeping in both gut and a sterile
site infection (OR=1; CI= 2.04–1). There is a large body of
evidence that bacterial infection plays a role in the events trigger-
ing SIDS. [Many of the pathology findings are compatible with a
process of bacterial sepsis together with the physiological findings
of hypoxemia and bradyasystole followed by gasping, (50) point to
bacterial sepsis/toxemia as the final event in SIDS pathogenesis.]
E. coli in SIDS and Inflammation
A history of diarrheal illness in the last week of life is a frequent
finding in SIDS (46). Nelson et al. (54) supports the probability of
the occurrence of gut inflammatory changes in SIDS. In general
inflammation of the gut in SIDS has not been widely studied, but
supportive evidence of compatible histological changes has been
published (68) and examination of autopsy reports frequently
shows hyperplasia of germinal centers and follicular hyperplasia
of mesenteric lymph nodes.
A recent study (69) showed that infection by enteric pathogens,
such as Salmonella enterica serovar Typhimurium (S. Tm), is
antagonized by a highly complex intestinal microbiome, i.e., colo-
nization resistance. Disruption of colonization resistance by such
conditions as antibiotic therapy, a germfree state or an immature
microbiome of low complexity results in increased susceptibility
to oral infection with pathogens of the Enterobacteriaceae family
(70–72). Pathogen (e.g., S. Tm)-induced gut inflammation pro-
motes parallel blooms of S. Tm and host commensal E. coli. These
blooms out-compete residual microbiota with E. coli and other
Enterobacteriaceae taking advantage of the inflammatory condi-
tions. The bacteria compete successfully for resources by directly
antagonizing competitors by producing antimicrobials including
bacteriocins. The bacteriocins produced by Enterobacteriaceae are
colicins. Blooms of commensal and pathogenicEnterobacteriaceae
exploit the abundant conditions provided by the inflamed gut (73–
75). In man, up to 15 different E. coli strains can be detected in the
gut microbiome (72). The success of the inflammation-induced
enterobacterial bloom has been attributed to colicins, such as
ColIb (cib), which provides effective defense against competing
bacteria. Expression of cib andCirA (the cognate outermembrane
receptor of cib on colicin-sensitive E. coli), is regulated by iron
limitation. In the context of SIDS, and on the basis of epidemiolog-
ical evidence of diarrheal symptoms in the days preceding death,
and the sterile site data (33, 44, 45) it is plausible that invoked
inflammation of the gut could lead to translocation of bacteria
from the gut lumen into the portal and systemic blood stream and
thence provide the stimulus for a lethal cytokine storm. It is clear
that detailed analysis of the gut in SIDS and themicrobiomewithin
are neglected areas of research. In time, this approach might
provide important clues to the SIDS enigma. If the studies by
Gómez-Moreno et al. (76) are shown to be universally applicable
then testing fecal specimens for the several genes of bacterial
origin, which had been previously associated with inflammation
may well be seen as risk factors for SIDS and treatment to remove
these bacteria may well be achievable. Until such studies (76)
are universally undertaken as part of the forensic investigation
into the sudden death of an infant, full conclusions cannot be
drawn.
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